
Mikascot 500 Injection
Marketer
Scott Edil Pharmacia Ltd
Salt Composition
Amikacin (500mg)
Overview Mikascot 500 Injection
Cefamox 500 Injection is a broad-spectrum antibiotic combating various bacterial infections. These encompass urinary tract, bone, joint, lung (such as pneumonia), brain, and bloodstream infections, among others. Prophylactic use in hospitalized patients is also indicated. Cefamox 500 Injection inhibits bacterial proliferation. Administered intravenously (drip) or via intramuscular/intravenous injection by a healthcare professional, self-administration is strictly prohibited. Adherence to the prescribed dosage schedule is crucial; complete the entire course, even with symptom improvement, to prevent relapse. Premature cessation may exacerbate the infection. Common adverse effects include injection site reactions and elevated blood urea nitrogen (BUN) levels. Persistent side effects or lack of improvement warrant medical consultation. High-dose therapy may exceptionally cause vertigo, nephrotoxicity, and ototoxicity. Close monitoring, including renal function, audiological, and urinalysis assessments, may be implemented. Pregnancy contraindicates its use; disclose pregnancy, pregnancy plans, or breastfeeding to your physician.
Uses of Mikascot 500 Injection
Infections caused by bacteria
Major Benefits of Mikascot 500 Injection:
Administering this medication will be done by your physician or their associate; please refrain from self-medicating.
Common Side effects of Mikascot 500 Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikascot 500 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Mikascot 500 Injection works:
Mikascot 500 Injection is a bacterial growth inhibitor, functioning as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from co-ingesting Mikascot 500 Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Mikascot 500 Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use necessary if the potential advantages outweigh the hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Mikascot 500 poses no known risk to nursing infants. Research in humans indicates minimal to negligible transfer of the drug into breast milk, suggesting no harm to the baby.
DrivingUNSAFE
Administering Mikascot 500 Injection may induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCAUTION
Patients with kidney impairment should use Mikascot 500 Injection cautiously; dosage modification may be necessary. Seek medical advice before administration.
LiverSAFE IF PRESCRIBED
Mikascot 500 Injection appears to pose minimal risk for individuals with hepatic impairment. Preliminary findings indicate that dosage modification may be unnecessary in this population. Physician consultation is recommended.
What if you forget to take Mikascot 500 Injection :
Should you forget a scheduled dose of Mikascot 500 Injection, seek your physician's advice.
Facts to Know About Mikascot 500 Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Actions | Aminoglycoside antibiotics |
